Zacksman is spreading the word of Zacks Investment Research to the many readers unfamiliar with the power of the Zacks Rank. He is adding new content from Zacks Analysts and Editors daily.
Zacks News Feed- Investing Lessons Learned from 2009 January 1, 2010The goal of this article is to learn from both the good moves and the bad in order to invest even more successfully in 2010.
- Steel Output Rises Again - Analyst Blog December 31, 2009Global crude steel production for the 66 countries reporting to Worldsteel improved 24.2% year over year to 107.5 million tons.
- Consumer Payments Trend Down - Analyst Blog December 31, 2009Consumer delinquency rates for bankcards, first mortgages and home equity lines of credit increased on a month-to-month basis in November 2009.
- Geely Optimistic About Volvo - Analyst Blog December 31, 2009Geely is close to acquiring Volvo in early 2010, with strong support from the Chinese Government.
- School Specialty Upped to Neutral - Analyst Blog December 31, 2009We have upgraded our recommendation on School Specialty Inc. to Neutral from Underperform, buoyed by its initiative to reduce overheads and boost profitability.
- Morgan Indicted for CDO Fraud - Analyst Blog December 31, 2009Morgan Stanley is accused of swindling investors by promoting $1.2 billion of risky low-quality mortgage-related notes in 2007 that it had already perceived to be non-profitable.
- FDA Clears ZOLL Product - Analyst Blog December 31, 2009ZOLL Medical Corporation announced that the U.S. Food and Drug Administration has approved the marketing of its E series defibrillators equipped with carbon monoxide monitoring.
- Vodafone Buys Turkish Operator - Analyst Blog December 31, 2009Vodafone Group Plc is reportedly buying the entire stake in the Turkish fixed-line voice and Internet service provider Borusan Telekom.
- Lockheed F-16s Fly Egypt - Analyst Blog December 31, 2009Lockheed Martin Corporation will sell 24 F-16 fighter aircraft to Egypt for more than $3.2 billion.
- Pipeline Setback for JNJ - Analyst Blog December 31, 2009Johnson and Johnson has received a complete response letter from the US Food and Drug Administration for its pipeline candidate ceftobiprole, delaying the approval process further.
- Investing Lessons Learned from 2009 January 1, 2010
